Pervanadate-triggered MAP kinase activation and cell proliferation are not sensitive to PD 98059. Evidence for stimulus-dependent differential PD 98059 inhibition mechanism.
A tight and stable complex with corresponding protein kinases and phosphatases establishes coupling between activators and inactivators. One such example is emerging from the studies of the Ras-dependent MAP kinase cascade signaling pathway. Pervanadate, a potent inhibitor of protein tyrosine phosphatase, stimulates MAP kinase and elicits cell proliferation in cultured mouse fibroblasts which is insensitive to PD 98059, the major inhibitor of upstream MEK, whereas serum- or TPA-triggered proliferation is sensitive to PD 98059. It is suggested that imbalanced coordination between protein kinase and protein phosphatase determines the cellular responses such as cell proliferation. The PD 98059-insensitive cell proliferation upon protein tyrosine phosphatase inhibition is attributed to a MEK bypass pathway.
Krady
M M
MM
Laboratoire de Neurobiologie Moléculaire des Interactions Cellulaires, CNRS UPR 416, Strasbourg, France.
Malviya
A N
AN
Dupont
J L
JL
D000818:Animals; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000378:metabolism*; D002455:Cell Division / Q000187:drug effects*; D002478:Cells, Cultured; D004789:Enzyme Activation; D005419:Flavonoids / Q000494:pharmacology*; D007150:Immunohistochemistry; D051379:Mice; D008809:Mice, Inbred C3H; D015398:Signal Transduction; D014638:Vanadates / Q000494:pharmacology*
D005419:Flavonoids; C076715:pervanadate; D014638:Vanadates; D017871:Calcium-Calmodulin-Dependent Protein Kinases; C093973:2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one